Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason M Glanz

Showing results (61-70 of 146) with videos related to

Pageof 15
Sort By:
BMJ Public Health|October 18, 2024
Effectiveness of direct patient outreach with a narrative naloxone and overdose prevention video to patients prescribed long-term opioid therapy in the USA: the Naloxone Navigator randomised clinical trialJason M Glanz, Shane R Mueller, Komal J Narwaney, et al.
JAMA Network Open|October 5, 2022
Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan DisenrollmentIngrid A Binswanger, Susan M Shetterly, Stanley Xu, et al.
Preventive Medicine Reports|January 11, 2024
Association between severe acute respiratory syndrome coronavirus 2 antibody status and reinfection: A case-control study nested in a Colorado-based prospective cohort studyIngrid A Binswanger, Komal J Narwaney, Jennifer C Barrow, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|December 19, 2018
Novel Opioid Safety Clinic Initiative to Deliver Guideline-Concordant Chronic Opioid Therapy in Primary CareIngrid A Binswanger, Nicole Joseph, Rebecca Hanratty, et al.
Substance Abuse|September 13, 2023
Association Between Opioid Dose Reduction Rates and Overdose Among Patients Prescribed Long-Term Opioid TherapyJason M Glanz, Stanley Xu, Komal J Narwaney, et al.
Vaccine|February 3, 2016
White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety DatalinkJason M Glanz, Sophia R Newcomer, Michael L Jackson, et al.
The International Journal on Drug Policy|October 24, 2025
Impact of increased criminal penalties for fentanyl possession on initiation and retention on medications for opioid use disorder in ColoradoXiaoyu Guan, Cole Jurecka, Pranav Padmanabhan, et al.
Pediatrics|July 25, 2023
Failure to Complete Multidose Vaccine Series in Early ChildhoodSarah Y Michels, Linda M Niccolai, James L Hadler, et al.
Journal of Clinical Epidemiology|July 11, 2006
Four different study designs to evaluate vaccine safety were equally validated with contrasting limitationsJason M Glanz, David L McClure, Stanley Xu, et al.
Preventive Medicine Reports|September 6, 2024
Association of chronic opioid therapy and opioid use disorder with COVID-19-related hospitalization and mortality: Evidence from three health systems in the United StatesAnh P Nguyen, Ingrid A Binswanger, Komal J Narwaney, et al.
Pageof 15

Showing results (61-70 of 146) with videos related to

Sort By:
Pageof 15
BMJ Public Health|October 18, 2024
Effectiveness of direct patient outreach with a narrative naloxone and overdose prevention video to patients prescribed long-term opioid therapy in the USA: the Naloxone Navigator randomised clinical trialJason M Glanz, Shane R Mueller, Komal J Narwaney, et al.
JAMA Network Open|October 5, 2022
Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan DisenrollmentIngrid A Binswanger, Susan M Shetterly, Stanley Xu, et al.
Preventive Medicine Reports|January 11, 2024
Association between severe acute respiratory syndrome coronavirus 2 antibody status and reinfection: A case-control study nested in a Colorado-based prospective cohort studyIngrid A Binswanger, Komal J Narwaney, Jennifer C Barrow, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|December 19, 2018
Novel Opioid Safety Clinic Initiative to Deliver Guideline-Concordant Chronic Opioid Therapy in Primary CareIngrid A Binswanger, Nicole Joseph, Rebecca Hanratty, et al.
Substance Abuse|September 13, 2023
Association Between Opioid Dose Reduction Rates and Overdose Among Patients Prescribed Long-Term Opioid TherapyJason M Glanz, Stanley Xu, Komal J Narwaney, et al.
Vaccine|February 3, 2016
White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety DatalinkJason M Glanz, Sophia R Newcomer, Michael L Jackson, et al.
The International Journal on Drug Policy|October 24, 2025
Impact of increased criminal penalties for fentanyl possession on initiation and retention on medications for opioid use disorder in ColoradoXiaoyu Guan, Cole Jurecka, Pranav Padmanabhan, et al.
Pediatrics|July 25, 2023
Failure to Complete Multidose Vaccine Series in Early ChildhoodSarah Y Michels, Linda M Niccolai, James L Hadler, et al.
Journal of Clinical Epidemiology|July 11, 2006
Four different study designs to evaluate vaccine safety were equally validated with contrasting limitationsJason M Glanz, David L McClure, Stanley Xu, et al.
Preventive Medicine Reports|September 6, 2024
Association of chronic opioid therapy and opioid use disorder with COVID-19-related hospitalization and mortality: Evidence from three health systems in the United StatesAnh P Nguyen, Ingrid A Binswanger, Komal J Narwaney, et al.
Pageof 15